Edition:
United States

Marinus Pharmaceuticals Inc (MRNS.OQ)

MRNS.OQ on NASDAQ Stock Exchange Global Market

3.26USD
3:59pm EST
Change (% chg)

$-0.12 (-3.55%)
Prev Close
$3.38
Open
$3.35
Day's High
$3.43
Day's Low
$3.22
Volume
75,654
Avg. Vol
272,751
52-wk High
$10.54
52-wk Low
$2.37

Chart for

About

Marinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. Its clinical-stage product candidate, ganaxolone, is a modulator being developed in various dose forms, including intravenous, oral... (more)

Overall

Beta: 3.26
Market Cap(Mil.): $166.96
Shares Outstanding(Mil.): 40.53
Dividend: --
Yield (%): --

Financials

  MRNS.OQ Industry Sector
P/E (TTM): -- 29.45 30.88
EPS (TTM): -0.86 -- --
ROI: -64.34 14.34 13.80
ROE: -64.49 15.85 15.29

Earnings vs. Estimates